Clinical trial
Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
NCT01063010 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- February 28, 2010
- Completion date
- January 31, 2015
- Enrollment
- 0 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock